Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women

被引:16
作者
Greco, D. [1 ]
Kocyigit, D. [2 ,8 ]
Adorni, M. P. [3 ]
Marchi, C. [3 ]
Ronda, N. [3 ]
Bernini, F. [3 ]
Gurses, K. M. [4 ,9 ]
Canpinar, H. [5 ]
Guc, D. [5 ]
Oguz, S. H. [6 ]
Gurlek, A. [6 ]
Strazzella, A. [7 ]
Simonelli, S. [7 ]
Tokgozoglu, L. [2 ]
Zimetti, F. [3 ]
机构
[1] Univ Parma, Biopharmanet Tec Ctr, Parma, Italy
[2] Hacettepe Univ, Fac Med, Dept Cardiol, Ankara, Turkey
[3] Univ Parma, Dept Food & Drug, Parco Area Sci 27-A, I-43124 Parma, Italy
[4] Univ Hlth Sci, Konya Training & Res Hosp, Dept Cardiol, Konya, Turkey
[5] Hacettepe Univ, Canc Inst, Dept Basic Oncol, Ankara, Turkey
[6] Hacettepe Univ, Fac Med, Dept Internal Med, Sect Endocrinol & Metab, Ankara, Turkey
[7] Univ Milan, Dipartimento Sci Farmacol & Biomol, Ctr E Grossi Paoletti, Milan, Italy
[8] Afyonkarahisar Dinar State Hosp, Cardiol Clin, Afyon, Turkey
[9] Adnan Menderes Univ, Fac Med, Dept Basic Med Sci, Aydin, Turkey
关键词
Vitamin D; HDL; Cholesterol efflux capacity; Macrophage; Adiponectin; Resistin; Atherosclerosis; HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; CHOLESTEROL EFFLUX; D SUPPLEMENTATION; D DEFICIENCY; CAPACITY; METABOLISM; EXPRESSION; MARKERS; IMPACT;
D O I
10.1016/j.numecd.2018.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Low vitamin D (vitD) has been linked to increased cardiovascular (CV) risk, but the effects of vitD supplementation are not clarified. We evaluated the impact of vitD normalization on HDL cholesterol efflux capacity (CEC), which inversely correlates with CV risk, the proatherogenic serum cholesterol loading capacity (CLC), adipokine profile and subclinical atherosclerosis. Methods and results: Healthy premenopausal women with vitD deficiency (n = 31) underwent supplementation. Subclinical atherosclerosis was evaluated by flow-mediated dilation (FMD), pulse wave velocity (PWV) and augmentation index (AIx), measured with standard techniques. HDL CEC and serum CLC were measured by a radioisotopic and fluorimetric assay, respectively. Malondialdehyde (MDA) in HDL was quantified by the TBARS assay. Pre-beta HDL was assessed by 2D-electrophoresis. Serum adipokines were measured by ELISA. VitD replacement restored normal levels of serum 25-hydroxyvitamin D (25OHD) and significantly improved FMD (+4%; p < 0.001), PWV (-4.1%: p < 0.001) and AIx (-16.1%; p < 0.001). Total CEC was significantly improved (+19.5%; p = 0.003), with a specific increase in the ABCA1-mediated CEC (+70.8%; p < 0.001). HDL-MDA slightly but significantly decreased (-9.6%; p = 0.027), while no difference was detected in pre-beta HDL. No change was observed in aqueous diffusion nor in the ABCG1-mediated CEC. Serum CLC was significantly reduced (-13.3%; p = 0.026). Levels of adiponectin were increased (+50.6%; p < 0.0001) and resistin levels were decreased ( -24.3%; p < 0.0001). After vitD replacement, an inverse relationship was found linking the ABCA1-mediated CEC with pre-beta HDL (r(2) = 0.346; p < 0.001) and resistin (r(2) = 0.220; p = 0.009). Conclusion: Our data support vitD supplementation for CV risk prevention. (C) 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:822 / 829
页数:8
相关论文
共 36 条
[1]   Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis [J].
Adorni, M. P. ;
Zimetti, F. ;
Puntoni, M. ;
Bigazzi, F. ;
Sbrana, F. ;
Minichilli, F. ;
Bernini, F. ;
Ronda, N. ;
Favari, E. ;
Sampietro, T. .
JOURNAL OF LIPID RESEARCH, 2012, 53 (05) :984-989
[2]   Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9 [J].
Adorni, Maria Pia ;
Ferri, Nicola ;
Marchiano, Silvia ;
Trimarco, Valentina ;
Rozza, Francesco ;
Izzo, Raffaele ;
Bernini, Franco ;
Zimetti, Francesca .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 :1555-1562
[3]   HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target [J].
Bhatt, Anish ;
Rohatgi, Anand .
CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (01) :1-8
[4]   Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D [J].
Carrara, Davide ;
Bruno, Rosa Maria ;
Bacca, Alessandra ;
Taddei, Stefano ;
Duranti, Emiliano ;
Ghiadoni, Lorenzo ;
Bernini, Giampaolo .
JOURNAL OF HYPERTENSION, 2016, 34 (11) :2199-2205
[5]   Vitamin D, Calcium, and Cardiovascular Disease: A"D"vantageous or "D"etrimental? An Era of Uncertainty [J].
Chin, Kathleen ;
Appel, Lawrence J. ;
Michos, Erin D. .
CURRENT ATHEROSCLEROSIS REPORTS, 2017, 19 (01)
[6]   VITAMIN D: METABOLISM, MOLECULAR MECHANISM OF ACTION, AND PLEIOTROPIC EFFECTS [J].
Christakos, Sylvia ;
Dhawan, Puneet ;
Verstuyf, Annemieke ;
Verlinden, Lieve ;
Carmeliet, Geert .
PHYSIOLOGICAL REVIEWS, 2016, 96 (01) :365-408
[7]   The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages [J].
de la Llera-Moya, Margarita ;
Drazul-Schrader, Denise ;
Asztalos, Bela F. ;
Cuchel, Marina ;
Rader, Daniel J. ;
Rothblat, George H. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (04) :796-U343
[8]   Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis [J].
Di Pietro, Natalia ;
Formoso, Gloria ;
Pandolfi, Assunta .
VASCULAR PHARMACOLOGY, 2016, 84 :1-7
[9]   Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials [J].
Dinca, Madalina ;
Serban, Maria-Corina ;
Sahebkar, Amirhossein ;
Mikhailidis, Dimitri P. ;
Toth, Peter P. ;
Martin, Seth S. ;
Blaha, Michael J. ;
Blueher, Matthias ;
Gurban, Camelia ;
Penson, Peter ;
Michos, Erin D. ;
Hernandez, Adrian V. ;
Jones, Steven R. ;
Banach, Maciej .
PHARMACOLOGICAL RESEARCH, 2016, 107 :360-371
[10]   Depletion of pre-β-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1-but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein [J].
Favari, E ;
Lee, M ;
Calabresi, L ;
Franceschini, G ;
Zimetti, F ;
Bernini, F ;
Kovanen, PT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) :9930-9936